Treatment of Rumination
NCT06971354 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-07-09
Summary
Background: Rumination syndrome is characterized by the involuntary regurgitation of previously ingested food from the stomach to the mouth, triggered by an unintentional contraction of the abdominal muscles along with simultaneous relaxation of the esophageal sphincters. Based on this mechanism, a biofeedback technique targeting muscular activity has been developed and shown to be effective. However, such techniques are often complex and not widely accessible.
Hypothesis: Rumination can be effectively treated using a simplified, non-instrumental biofeedback technique based on cognitive intervention.
Objective: To evaluate the effectiveness of a non-instrumental biofeedback technique incorporating cognitive intervention for the treatment of rumination. The methodology will build on prior studies, employing a more streamlined biofeedback approach.
Methods: Participants will be assigned to parallel groups with balanced sex distribution. The study will compare responses to biofeedback versus a control intervention. Over a four-week period, each participant will undergo three treatment sessions:
The biofeedback group will be trained to control abdominothoracic musculature through cognitive intervention, supported by original visual materials, both before and after a standardized test meal.
The control group will receive a placebo capsule prior to the test meal, and regurgitation episodes will be recorded.
Following the initial session, biofeedback participants will continue with daily exercises, while control participants will take a placebo with each meal. Treatment response will be assessed by comparing outcomes before and after the intervention. After post-treatment assessment, control group participants will be offered the opportunity to receive biofeedback therapy.
Relevance: This project aims to determine the efficacy of a simplified mechanistic intervention for rumination. If successful, this approach could be adopted in additional healthcare settings.
Conditions
- Rumination Syndrome
Interventions
- BEHAVIORAL
-
Biofeedback
Three sessions of biofeedback before and after a standardized meal.
- DIETARY_SUPPLEMENT
-
Placebo
Three sessions of placebo followed by standardized meal.
Sponsors & Collaborators
-
Hospital Universitari Vall d'Hebron Research Institute
lead OTHER
Principal Investigators
-
Jordi Serra, M.D. · Vall d'Hebron Research Institute, Barcelona, 08035
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-02
- Primary Completion
- 2026-05-31
- Completion
- 2026-10-31
Countries
- Spain
Study Locations
More Related Trials
-
Treatment of Globus Sensations With Psychotherapy
NCT01590992 ·Status: COMPLETED ·Phase: NA
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
NCT06883175 ·Status: RECRUITING ·Phase: NA
-
Physiology of GERD and Treatment Response
NCT04292470 ·Status: COMPLETED ·Phase: NA
-
Buspirone for Weak or Absent Esophageal Peristalsis
NCT05629325 ·Status: RECRUITING ·Phase: PHASE4
-
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
NCT05561179 ·Status: UNKNOWN ·Phase: NA
-
Topical Bethanechol for Improvement of Esophageal Dysmotility
NCT01031043 ·Status: COMPLETED ·Phase: PHASE1
-
Facilitation of Oral Bolus Propulsion Using Electropalatography in Patients With Dysphagia
NCT00001718 ·Status: COMPLETED ·Phase: NA
-
Esophageal Bolus Transit in Newborns With Gastroesophageal Reflux Disease
NCT02167984 ·Status: COMPLETED
-
Cognitive-behavioral Therapy for the Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
NCT06939465 ·Status: RECRUITING ·Phase: NA
-
Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of Gastroesophageal Reflux Disease (GERD)
NCT04960566 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effects of Serotonin Agonist Buspirone on Multimodal Esophageal Stimulation in Healthy Volunteers
NCT04352686 ·Status: COMPLETED ·Phase: NA
-
Structure and Function of the Gastro-esophageal Junction
NCT01053585 ·Status: COMPLETED ·Phase: NA
-
Pressure and Flow Study Before and After Treatments for EMD. The pFlow Study
NCT03904004 ·Status: UNKNOWN
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
NCT03411252 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Efficacy of Gut-Brain Neuromodulators in the Treatment of Gastroesophageal Reflux Disease
NCT06945237 ·Status: COMPLETED ·Phase: NA
-
Effect of MIST on Esophageal Sensitivity in Patients With rGERD
NCT05429034 ·Status: UNKNOWN ·Phase: NA
-
Response to Supplement and Placebo in GERD
NCT01915173 ·Status: COMPLETED ·Phase: NA
-
Salivary Biomarkers of Gastroesophageal Reflux in Infants
NCT05821348 ·Status: UNKNOWN ·Phase: NA
-
"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?
NCT06495606 ·Status: RECRUITING
-
Treatment Use of Domperidone for Gastroparesis
NCT02227927 ·Status: NO_LONGER_AVAILABLE
-
Reletex for Nausea in GERD Patients
NCT01582100 ·Status: TERMINATED ·Phase: NA
-
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
NCT02972047 ·Status: COMPLETED ·Phase: NA
-
Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease
NCT06215794 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Usefulness and Influence on Esophageal Motility of Pyridostigmine for Dysphagia in Systemic Sclerosis
NCT06915181 ·Status: WITHDRAWN ·Phase: PHASE2